Albert Einstein Cancer Center

The Bronx, New York 10461

0 studies enrolling now · 9 studies all time

What they study most

Adult T Cell Leukemia, Adult T Cell Lymphoma, Advanced Cancer, Advanced Malignant Solid Tumors, Advanced Solid Tumors, Anaplastic Large-Cell Lymphoma, Bladder Cancer, Breast Cancer, Cancer, Metastasis, Neoplasms, Non-Hodgkin Lymphoma

Studies at this site

• A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma — Stopped early
• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• OSI-774 (Erlotinib, Tarceva) in Elderly Patients — Completed
• Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer — Completed
• Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer — Stopped early
• Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin — Completed
• Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer — Completed
• Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed